Cargando…
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors
[Image: see text] N-Myristoyltransferase (NMT) represents a promising drug target within the parasitic protozoa Trypanosoma brucei (T. brucei), the causative agent for human African trypanosomiasis (HAT) or sleeping sickness. We have previously validated T. brucei NMT as a promising druggable target...
Autores principales: | Bayliss, Tracy, Robinson, David A., Smith, Victoria C., Brand, Stephen, McElroy, Stuart P., Torrie, Leah S., Mpamhanga, Chido, Norval, Suzanne, Stojanovski, Laste, Brenk, Ruth, Frearson, Julie A., Read, Kevin D., Gilbert, Ian H., Wyatt, Paul G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734605/ https://www.ncbi.nlm.nih.gov/pubmed/29125744 http://dx.doi.org/10.1021/acs.jmedchem.7b01255 |
Ejemplares similares
-
Discovery of a Novel Class
of Orally Active Trypanocidal N-Myristoyltransferase
Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011) -
A Molecular Hybridization
Approach for the Design
of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
por: Harrison, Justin R., et al.
Publicado: (2018) -
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015) -
Lead Optimization of a Pyrazole
Sulfonamide Series
of Trypanosoma bruceiN-Myristoyltransferase Inhibitors: Identification and Evaluation
of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human
African Trypanosomiasis
por: Brand, Stephen, et al.
Publicado: (2014) -
N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010)